Cellebrite DI Ltd (CLBT) FinancialsCLBTCellebrite DI Ltd

Evaluating the bottom line, Cellebrite DI Ltd maintains a gross margin of 80.78%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at 5.82%, while the net margin is 4.86%. These profitability ratios, combined with a Return on Equity (ROE) of 12.31%, provide a clear picture of how effectively CLBT converts its operational activities into shareholder value.

In the context of the broader market, CLBT competes directly with industry leaders such as AVPT and APPN. With a market capitalization of $3.08B, it holds a leading position in the sector. When comparing efficiency, CLBT's gross margin of 80.78% stands against AVPT's 73.10% and APPN's 71.21%. Such benchmarking helps identify whether Cellebrite DI Ltd is trading at a premium or discount relative to its financial performance.

Cellebrite's revenue for Q2 was $131 million, a 16% increase year-over-year, but it fell short of analyst expectations. The company also reported a net income of $6.37 million for Q2 2026, down from $10.94 million in Q1 2026, indicating a decline in profitability.